There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

CAMBRIDGE, MA, USA I March 11, 2025 I Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase ...

It was five years ago today that then-Gov. Charlie Baker declared a State of Emergency in Massachusetts due to the rapidly ...

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

Denali Therapeutics Inc.’s DNLI share price has dipped by 10.43%, which has investors questioning if this is right time to buy.

Massachusetts-based Biogen will pay Forward $1.25 billion upfront, and under a licence agreement may pay future royalties from Tecfidera dependent on ongoing patent cases in US and EU.

Massachusetts-based Biogen also has exclusive rights to nominate up to nine additional undisclosed targets over a target selection period of five years. Sangamo will perform early research ...

Learn more about whether Ionis Pharmaceuticals, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...

March 11, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the efficacy and ...

Lantheus Holdings, Inc.'s stock soars 55%, fueled by Pylarify and strategic acquisitions in Alzheimer's and oncology. Click ...